Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression

References

• Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
   PubMed Web of Science ®Google Scholar
• Orman G, Tran Brandon H, Desai N, et al. Neuroimaging characteristics of nasopharyngeal carcinoma in children. J Neuroimaging. 2021;31(1):137–143.
   PubMed Web of Science ®Google Scholar
• Luo W-R, Chen X-Y, Li S-Y, et al. Neoplastic spindle cells in nasopharyngeal carcinoma show features of epithelial-mesenchymal transition. Histopathology. 2012;61(1):113–122.
   PubMed Web of Science ®Google Scholar
• Lee AWM, Ngan RKC, Ng WT, et al. NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma. Cancer. 2020;126:3674–3688.
   PubMed Web of Science ®Google Scholar
• Yan P, Yin H, Guo W, et al. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: an open labeled, randomized, controlled, and multicenter clinical trial. Cancer Med. 2020;9(17):6166–6172.
   PubMed Web of Science ®Google Scholar
• Ben-Ami T, Ash S, Ben-Harosh M, et al. Nasopharyngeal carcinoma in children and young adults-beyond 5-year survival. Pediatr Blood Cancer. 2020;67:e28494.
   PubMed Web of Science ®Google Scholar
• Ho JS, Di Tullio F, Schwarz M, et al. HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness. Elife. 2021;10. DOI:10.7554/eLife.59654
   Web of Science ®Google Scholar
• Tian-Zhao D, Yang Y, Xing-Xuan W, et al. Profiling of circular RNAs and circTPCN/miR-634/mTOR regulatory pathway in cervical cancer. Genomics. 2021;113(4):2253–2263.
   PubMed Web of Science ®Google Scholar
• Gao C, Xu YJ, Qi L, et al. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol Toxicol. 2021. DOI:10.1007/s10565-021-09613-0
   Web of Science ®Google Scholar
• Tu J, Chen W, Zheng L, et al. Circular RNA Circ0021205 promotes cholangiocarcinoma progression through MiR-204-5p/RAB22A axis. Front Cell Dev Biol. 2021;9:653207.
   PubMed Web of Science ®Google Scholar
• Martín J, Castellano JJ, Marrades RM, et al. Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer. Transl Lung Cancer Res. 2021;10(4):1804–1818.
   PubMed Web of Science ®Google Scholar
• Huang Y, Dai Y, Wen C, et al. circSETD3 contributes to acquired resistance to gefitinib in non-small-cell lung cancer by targeting the miR-520h/ABCG2 pathway. Mol Ther Nucleic Acids. 2020;21:885–899.
   PubMedGoogle Scholar
• Tao F, Gu C, Li N, et al. New biomarker for lung cancer - focus on circSETD3. J Biol Regul Homeost Agents. 2021;35:583–591.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Z, Xu S, et al. Novel potential tumor biomarkers: circular RNAs and exosomal circular RNAs in gastrointestinal malignancies. J Clin Lab Anal. 2020;34:e23359.
   PubMed Web of Science ®Google Scholar
• Tang L, Xiong W, Zhang L, et al. circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. Oncogene. 2021;40(2):307–321.
   PubMed Web of Science ®Google Scholar
• Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147–160.
   PubMed Web of Science ®Google Scholar
• Costa RLB, Han HS, Gradishar WJ. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review. Breast Cancer Res Treat. 2018;169:397–406.
   PubMed Web of Science ®Google Scholar
• Lin FJ, Lin XD, Xu LY, et al. Long noncoding RNA HOXA11-AS modulates the resistance of nasopharyngeal carcinoma cells to cisplatin via miR-454-3p/c-Met. Mol Cells. 2020;43:856–869.
   PubMed Web of Science ®Google Scholar
• Wang S, Song Z, Gong X, et al. Chloroform extract from Sophora Tonkinensis Gagnep. Inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;271:113879.
   PubMed Web of Science ®Google Scholar
• Huang ML, Qi CL, Zou Y, et al. Plac8-mediated autophagy regulates nasopharyngeal carcinoma cell function via AKT/mTOR pathway. J Cell Mol Med. 2020;24:7778–7788.
   PubMed Web of Science ®Google Scholar
• Hu JM, He LJ, Wang PB, et al. Antagonist targeting miR-106b-5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4. Int J Mol Med. 2021;48. DOI:10.3892/ijmm.2021.5002
   Web of Science ®Google Scholar
• Cui H, Wang Q, Lei Z, et al. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation. J Exp Clin Cancer Res. 2019;38:350.
   PubMed Web of Science ®Google Scholar
• Qi L, Wang W, Zhao G, et al. Circular RNA circCCDC66 promotes glioma proliferation by acting as a ceRNA for miR-320a to regulate FOXM1 expression. Aging (Albany NY). 2021;13(13):17673–17689.
   PubMedGoogle Scholar
• Zhao X, Li D, Zhao ST, et al. MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7. Eur Rev Med Pharmacol Sci. 2019;23:9304–9312.
   PubMed Web of Science ®Google Scholar
• Ding J, Wang Q, Guo N, et al. CircRNA circ_0072995 promotes the progression of epithelial ovarian cancer by modulating miR-147a/CDK6 axis. Aging (Albany NY). 2020;12(17):17209–17223.
   PubMedGoogle Scholar
• Lu Y, Luan XR. miR-147a suppresses the metastasis of non-small-cell lung cancer by targeting CCL5. J Int Med Res. 2020;48(4):300060519883098.
   PubMedGoogle Scholar
• Aoki M, Fujishita T. Oncogenic roles of the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 2017;407:153–189.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhang P, Zhao Y, et al. Overexpressed circRANBP17 acts as an oncogene to facilitate nasopharyngeal carcinoma via the miR-635/RUNX2 axis. J Cancer. 2021;12(14):4322–4331.
   PubMed Web of Science ®Google Scholar
• Li W, Lu H, Wang H, et al. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107. Cancer Lett. 2021;499:301–313.
   PubMed Web of Science ®Google Scholar
• Hong X, Liu N, Liang Y, et al. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer. 2020;19:33.
   PubMed Web of Science ®Google Scholar
• Xu L, Feng X, Hao X, et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38(1):98.
   PubMed Web of Science ®Google Scholar
• Li H, Chen YK, Wan Q, et al. Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a/IFITM1 axis. Front Med (Lausanne). 2021;8:663558.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Li NN, Xu SJ, et al. A new and important relationship between miRNA-147a and PDPK1 in radiotherapy. J Cell Biochem. 2018;119:3519–3527.
   PubMed Web of Science ®Google Scholar
• Dai K, Chen L, Liu J, et al. MiR-147a mediated by sodium new houttuyfonate could enhance radiosensitivity of non-small cell lung cancer cells via suppressing STAT3. Adv Clin Exp Med. 2021;30(2):173–181.
   PubMed Web of Science ®Google Scholar